204 related articles for article (PubMed ID: 24229060)
21. Adverse drug reactions in the paediatric population in Denmark: a retrospective analysis of reports made to the Danish Medicines Agency from 1998 to 2007.
Aagaard L; Weber CB; Hansen EH
Drug Saf; 2010 Apr; 33(4):327-39. PubMed ID: 20297864
[TBL] [Abstract][Full Text] [Related]
22. Serious Adverse Events Associated with Off-Label Use of Azithromycin or Fentanyl in Children in Intensive Care Units: A Retrospective Chart Review.
Oshikoya KA; Wharton GT; Avant D; Van Driest SL; Fenn NE; Lardieri A; Doe E; Sood BG; Taketomo C; Lieu P; Yen L; McMahon AW
Paediatr Drugs; 2019 Feb; 21(1):47-58. PubMed ID: 30484072
[TBL] [Abstract][Full Text] [Related]
23. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
24. Patients' use of information about medicine side effects in relation to experiences of suspected adverse drug reactions: a cross-sectional survey in medical in-patients.
Krska J; Morecroft CW
Drug Saf; 2013 Aug; 36(8):673-80. PubMed ID: 23700262
[TBL] [Abstract][Full Text] [Related]
25. Off-label and unlicensed utilization of drugs in a Brazilian pediatric hospital.
Pereira Gomes V; Melo da Silva K; Oliveira Chagas S; dos Santos Magalhães IR
Farm Hosp; 2015 May; 39(3):176-80. PubMed ID: 26005894
[TBL] [Abstract][Full Text] [Related]
26. Adverse Drug Reactions in Paediatric In-Patients in a South African Tertiary Hospital.
Makiwane M; Decloedt E; Chirehwa M; Rosenkranz B; Kruger M
J Trop Pediatr; 2019 Aug; 65(4):389-396. PubMed ID: 30544245
[TBL] [Abstract][Full Text] [Related]
27. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
28. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
[TBL] [Abstract][Full Text] [Related]
30. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case-control study.
Liao PJ; Mao CT; Chen TL; Deng ST; Hsu KH
BMJ Open; 2019 May; 9(5):e026771. PubMed ID: 31079084
[TBL] [Abstract][Full Text] [Related]
32. Off-label and unlicensed medicine use and adverse drug reactions in children: a narrative review of the literature.
Mason J; Pirmohamed M; Nunn T
Eur J Clin Pharmacol; 2012 Jan; 68(1):21-8. PubMed ID: 21779968
[TBL] [Abstract][Full Text] [Related]
33. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.
Mouton JP; Mehta U; Parrish AG; Wilson DP; Stewart A; Njuguna CW; Kramer N; Maartens G; Blockman M; Cohen K
Br J Clin Pharmacol; 2015 Oct; 80(4):818-26. PubMed ID: 25475751
[TBL] [Abstract][Full Text] [Related]
34. Predictors of adverse drug reaction-related hospitalisation in Southwest Ethiopia: A prospective cross-sectional study.
Angamo MT; Curtain CM; Chalmers L; Yilma D; Bereznicki L
PLoS One; 2017; 12(10):e0186631. PubMed ID: 29036230
[TBL] [Abstract][Full Text] [Related]
35. Maltese prescribers use of off-label and unlicensed medicines in children: perceptions and attitudes.
Ellul I; Grech V; Attard-Montalto S
Int J Clin Pharm; 2016 Aug; 38(4):788-92. PubMed ID: 27142871
[TBL] [Abstract][Full Text] [Related]
36. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
37. Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit.
Gidey MT; Gebretsadkan YG; Tsadik AG; Welie AG; Assefa BT
Ital J Pediatr; 2020 Apr; 46(1):41. PubMed ID: 32245504
[TBL] [Abstract][Full Text] [Related]
38. [Knowledge creation about adverse drug reactions in the paediatric population].
Aagaard L
Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
[TBL] [Abstract][Full Text] [Related]
39. Safety and Efficacy of Off-label and Unlicensed Medicines in Children.
Lee JH; Byon HJ; Choi S; Jang YE; Kim EH; Kim JT; Kim HS
J Korean Med Sci; 2018 Sep; 33(37):e227. PubMed ID: 30190655
[TBL] [Abstract][Full Text] [Related]
40. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
